Humanigen Inc (HGENQ)

[DonDonDonDon]

Lots of chatter going on that CRP peer review is coming out pronto. That will be nice. The original peer review showed 54% efficacy on the primary endpoint which is very good but not amazing. The CRP peer review will show 243% efficacy on the primary endpoint. A lot of credible sources don't quote preprint numbers. When credible sources start quoting the 243% efficacy number, people will be very impressed. No therapeutic has efficacy anywhere close to that. The CRP mortality efficacy is even more impressive at 17.3% placebo mortality vs 7.5% lenz mortality. That is mind-boggling good. Again, no other therapeutic comes close.